About COVARIS
COVARIS is a founder-led clinical trial intelligence company focused on environmental extrinsic factors in clinical evidence generation and clinical trial planning.
The current commercial focus is planning-stage environmental screening for late phase 2 and phase 3 clinical trials. COVARIS helps sponsors and CROs screen planned trial countries, regions and enrollment windows for disease-relevant environmental instability before protocol lock.
In scoped cases, the same analytical foundation may also support realized environmental context around trial geographies during or after study conduct.
COVARIS is built for decision support and contextual interpretation. It does not claim to predict outcomes, prove causal effects or replace sponsor-led clinical, statistical or regulatory judgement.
Founder
COVARIS was founded by Allan S. Kristensen, who has worked for more than 25 years at the intersection of science, technology, innovation and international life-science ecosystems.
His background includes senior leadership roles in international innovation, science diplomacy and life-science collaboration across Denmark, Europe and the United States.
His academic background is an MSc in Technological and Socio-Economic Planning, also formally known as MSc in Sustainability Transitions, with a focus on the interaction between technological, environmental and societal systems.
COVARIS helps sponsors and CROs screen planned trial countries, regions and enrollment windows for disease-relevant environmental instability before protocol lock.
COVARIS does not predict outcomes or prove causal effects. It provides planning-stage environmental context intelligence for sponsor-led clinical trial decisions.
COVARIS ApS
2100 Copenhagen
Denmark
+45 25 30 30 28
CVR-no.: 46484673